gland pharma glp-1 capacity india net profit Jumps 50% in Q1 on market expansion; working to ramp up production by 3x, ETPharma Eli Lilly's $1 Billion India

Implications for Compounding Pharmacies and Prescribers (and Outsourcing Facilities) The April 1 clarification, read alongside FDA's escalating enforcement posture since early 2026, may signal a maturing and increasingly restrictive regulatory environment for GLP-1 compounding

Enzymatic synthesis of glutathione using yeast cells in two-stage reaction

Ahmad, M

Hsf-1 gene silencing: a potential therapeutic strategy for pancreatobiliary tumors

Finally, while the timing of observed changes aligns closely with the formulary update, this analysis does not establish causality, and other factors such as regional policies, supply dynamics, or provider preferences may have contributed

DPPH scavenging relies mainly on hydrogen atom transfer, with enhanced activity in both acidic and weakly alkaline environments